Favorable Government Policies to Drive Indian Clinical Trial Market

Top Quote With the availability of talented medical practitioners and low cost mechanism, the clinical trial market in India is expected to grow at a CAGR of 29% during 2009-2013. End Quote
  • (1888PressRelease) October 05, 2010 - According to our new research report "Booming Clinical Trials Market in India", the clinical trial market in India has grown from a small segment to a fast growing sector. The Indian clinical trial market has been witnessing a chain of positive changes that will lead to a splendid growth in future. Favorable government policies, cost effective R&D climate and a large pool of skilled manpower are some of the prominent factors driving the Indian clinical trial market. On the back of these factors and some other development boosters, the market is expected to grow at a CAGR of 29% during 2009-2013.

    The report has analyzed the Indian clinical trial market by emphasizing upon current market trends and growth drivers. For example - the pharma outsourcing market has been witnessing growth momentum due to clinical trial services being offered in India. Availability of skilled professionals and reasonable cost structure have prompted various healthcare providers and players to outsource their research activities.

    "Booming Clinical Trials Market in India" covers those sections of the Indian clinical trial market that provide glimpse of the current market and future outlook. For example, sections like 'clinical trial market overview' and 'cost analysis' give all the necessary information of the global and Indian clinical trial market along with cost expenditure on phases (I-IV). Moreover, the services offered in India have been compared with key countries to provide an optimum outlook of the sector.

    The report is an outcome of in-depth research and prudent analysis of the Indian clinical trial market. It utilizes some of the best techniques and methods to forecast sub-segments and related markets. Other than future forecast, the report provides a section on key Indian players and regulatory environment necessary to be described in order to complete the picture. The report has included all the necessary ingredients of the clinical trial market and will prove an effective resource for investment decision making.

    For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm

    Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

    About RNCOS:

    RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

  • FB Icon Twitter Icon In-Icon
Contact Information
  • Shushmul Maheshwari
  • Rncos
  • B 129 Sector 6
  • Noida 201301
  • 201301
  • Voice: 91-120-4224-700
  • Visit our Site